# Elite Pharmaceuticals Inc: filings

ELTP · OTC · CIK 1053369 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/eltp.md) · [Financials](/companies/eltp/financials.md) · [Filings](/companies/eltp/filings.md) · [Insiders](/companies/eltp/insiders.md)

## Reports and events: 320 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 317, 8-K 201, 10-Q 53, 4/A 40, CORRESP 21, UPLOAD 21, 10-K 18, 424B3 17, 3 15, CT ORDER 15, 8-K/A 10, 10-Q/A 9, SC 13G/A 9, 5 7, EFFECT 7, SC 13D/A 7, 10-K/A 6, SC 13D 6, D 5, DEF 14A 5, PRE 14A 5, S-8 5, 144 3, DEFA14A 3, NT 10-K 3, S-1 3, S-3 3, SC 13G 3, 3/A 2, POS AM 2, S-1/A 2, 25 1, 8-A12G 1, NT 10-Q 1, RW 1, S-3/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 20:17 ET | [8-K](/filings/0001493152-26-037787.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037787 |
| 2026-08-13 | 20:06 ET | [10-Q](/filings/0001493152-26-037752.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037752 |
| 2026-08-11 | 00:16 ET | [8-K/A](/filings/0001493152-26-036936.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036936 |
| 2026-08-10 | 21:07 ET | [8-K](/filings/0001493152-26-036905.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036905 |
| 2026-08-04 | 11:05 ET | [8-K](/filings/0001493152-26-035922.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035922 |
| 2026-06-29 | 20:51 ET | [8-K](/filings/0001493152-26-031103.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-031103 |
| 2026-06-29 | 20:05 ET | [10-K](/filings/0001493152-26-031070.md) | Annual report, period 2026-03-31 | 0001493152-26-031070 |
| 2026-06-23 | 11:02 ET | [8-K](/filings/0001493152-26-029700.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-029700 |
| 2026-06-15 | 11:02 ET | [8-K](/filings/0001493152-26-028610.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028610 |
| 2026-06-01 | 11:00 ET | [8-K](/filings/0001493152-26-026519.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-026519 |
| 2026-04-02 | 12:05 ET | [8-K](/filings/0001493152-26-014813.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-014813 |
| 2026-02-17 | 22:10 ET | [8-K](/filings/0001493152-26-007190.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-007190 |
| 2026-02-17 | 21:06 ET | [10-Q](/filings/0001493152-26-007104.md) | Quarterly report, period 2025-12-31 | 0001493152-26-007104 |
| 2026-02-11 | 21:35 ET | [8-K](/filings/0001493152-26-006213.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-006213 |
| 2025-11-14 | 22:10 ET | [8-K](/filings/0001493152-25-023629.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-023629 |
| 2025-11-14 | 21:11 ET | [10-Q](/filings/0001493152-25-023477.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023477 |
| 2025-11-12 | 22:19 ET | [8-K/A](/filings/0001493152-25-022013.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-022013 |
| 2025-11-12 | 12:15 ET | [8-K](/filings/0001493152-25-021717.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-021717 |
| 2025-11-10 | 12:15 ET | [8-K](/filings/0001493152-25-021392.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-021392 |
| 2025-08-14 | 20:37 ET | [8-K](/filings/0001641172-25-024088.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-024088 |
| 2025-08-14 | 20:16 ET | [10-Q](/filings/0001493152-25-011989.md) | Quarterly report, period 2025-06-30 | 0001493152-25-011989 |
| 2025-08-08 | 20:35 ET | [8-K](/filings/0001493152-25-011765.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-011765 |
| 2025-06-30 | 20:27 ET | [8-K](/filings/0001641172-25-017151.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017151 |
| 2025-06-30 | 20:05 ET | [10-K](/filings/0001641172-25-017134.md) | Annual report, period 2025-03-31 | 0001641172-25-017134 |
| 2025-06-23 | 11:05 ET | [8-K](/filings/0001641172-25-016000.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-016000 |
| 2025-06-16 | 11:05 ET | [8-K](/filings/0001641172-25-015172.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-015172 |
| 2025-04-30 | 20:40 ET | [8-K](/filings/0001641172-25-007836.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-007836 |
| 2025-03-03 | 12:10 ET | [8-K](/filings/0001493152-25-008808.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-008808 |
| 2025-02-13 | 21:56 ET | [8-K](/filings/0001493152-25-006471.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-006471 |
| 2025-02-13 | 21:05 ET | [10-Q](/filings/0001493152-25-006427.md) | Quarterly report, period 2024-12-31 | 0001493152-25-006427 |
| 2024-12-26 | 21:20 ET | [8-K](/filings/0001493152-24-052104.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-052104 |
| 2024-12-02 | 21:35 ET | [8-K](/filings/0001493152-24-048294.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-048294 |
| 2024-11-18 | 21:35 ET | [8-K](/filings/0001493152-24-046525.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-046525 |
| 2024-11-14 | 21:51 ET | [8-K](/filings/0001493152-24-046001.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-046001 |
| 2024-11-14 | 21:30 ET | [10-Q](/filings/0001493152-24-045933.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045933 |
| 2024-10-10 | 20:47 ET | [8-K](/filings/0001493152-24-040752.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-040752 |
| 2024-10-07 | 20:20 ET | [8-K](/filings/0001493152-24-040288.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-040288 |
| 2024-08-27 | 20:30 ET | [8-K](/filings/0001493152-24-034019.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-034019 |
| 2024-08-14 | 21:16 ET | [8-K](/filings/0001493152-24-032412.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-032412 |
| 2024-08-14 | 20:05 ET | [10-Q](/filings/0001493152-24-032154.md) | Quarterly report, period 2024-06-30 | 0001493152-24-032154 |
| 2024-07-01 | 21:21 ET | [8-K](/filings/0001493152-24-025848.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-025848 |
| 2024-07-01 | 20:59 ET | [10-K](/filings/0001493152-24-025829.md) | Annual report, period 2024-03-31 | 0001493152-24-025829 |
| 2024-06-21 | 20:07 ET | [8-K](/filings/0001493152-24-024720.md) | 1.01 Entry into a material agreement | 0001493152-24-024720 |
| 2024-06-05 | 20:07 ET | [8-K](/filings/0001493152-24-022732.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-24-022732 |
| 2024-05-20 | 20:30 ET | [8-K](/filings/0001493152-24-020707.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-020707 |
| 2024-02-14 | 21:55 ET | [8-K](/filings/0001493152-24-006722.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-006722 |
| 2024-02-14 | 21:06 ET | [10-Q](/filings/0001493152-24-006661.md) | Quarterly report, period 2023-12-31 | 0001493152-24-006661 |
| 2023-12-26 | 21:20 ET | [8-K](/filings/0001493152-23-046142.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-046142 |
| 2023-12-12 | 21:20 ET | [8-K](/filings/0001493152-23-044556.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-044556 |
| 2023-11-14 | 22:22 ET | [8-K](/filings/0001493152-23-041323.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-041323 |

Page 1 of 7. [Older](/companies/eltp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.